MedTech News

QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use

SAN DIEGO, Sept. 22, 2025 /PRNewswire/ — Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a leading global provider of innovative in vitro diagnostic technologies, is expanding its QUICKVUE portfolio with the QUICKVUE Influenza + SARS Test, a CLIA-waived, 510(k)–cleared rapid, easy-to-use immunoassay designed for professional use in physician office laboratories, urgent care centers, emergency departments, pharmacies and decentralized hospital labs.

Read More »

Diagnostic tool enables rapid leukemia subtype classification

Researchers at Dana-Farber Cancer Institute have developed a diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- and AI-guided Rapid Leukemia Subtype Inference), uses DNA methylation patterns and machine learning to classify acute leukemia with speed and accuracy

Read More »

Sign up for Blog Updates